BARBOSA JOSEPH has a total of 27 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are LAVOIE EDMOND J, TIBOTEC PHARM LTD and BYK GULDEN LOMBERG CHEM FAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | WIPO (World Intellectual Property Organization) | 10 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Barbosa Joseph | 27 |
#2 | Fink Cynthia Anne | 10 |
#3 | Wang Jian Cheng | 8 |
#4 | Dong Li | 7 |
#5 | Green Michael Alan | 6 |
#6 | Bi Yingzhi | 6 |
#7 | Wang Jiancheng | 5 |
#8 | Zipp G Gregory | 5 |
#9 | Han Qiang | 4 |
#10 | Gardyan Michael Walter | 4 |
Publication | Filing date | Title |
---|---|---|
US2008200458A1 | Methods and compositions for the treatment of body composition disorders | |
WO2008019276A2 | Solid forms of (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of their use | |
WO2006124897A2 | Methods and compositions for improving cognition | |
WO2004043367A2 | Fused heterocyclic compounds and use thereof | |
WO02102313A2 | Pyrimidine inhibitors of phosphodiesterase (pde) 7 |